Seek prompt medical attention if you experience any of the following: Severe or worsening pain, warmth, or swelling at the injection site, which may suggest infection Signs of an allergic reaction: rash, urticaria, facial swelling, difficulty breathing, or anaphylaxis Persistent or severe abdominal pain, which may indicate pancreatitis Right upper quadrant pain, fever, or jaundice, which may indicate gallbladder disease (e.g., cholelithiasis or cholecystitis) a recognised risk with incretin-class therapies Signs of dehydration from persistent vomiting or diarrhoea: reduced urine output, dizziness, or feeling faint on standing this may indicate acute kidney injury and requires urgent assessment Rapid heart rate, dizziness, or fainting Symptoms of hypoglycaemia (particularly if taking concomitant insulin or sulphonylureas): shakiness, sweating, confusion, or palpitations Any new or worsening visual symptoms, particularly if you have diabetes, as rapid improvement in blood glucose control has been associated with worsening of diabetic retinopathy in some patients [7] [8] In the UK, patients experiencing a severe or life-threatening reaction should call 999

We use minimal analytics to improve the calculator
The injection process bypasses the entire digestive system, which is precisely the point
If you have a procedure scheduled, do not take your GLP-1 injection early to "get ahead" of the hold period
The Future of Semaglutide and GLP-1 Agonists The success of semaglutide has shown that GLP-1 agonists can really change how we treat metabolic diseases, including cases with a body mass index associated with obesity
Healthy fats in controlled amounts are important for nutrient absorption and satiety